{
    "medicine_id": "8c332c716efcd69c650795cc5c325a18f2ea540a",
    "platform_id": "DB00926",
    "metadata": {
        "name": "Dibenzyline 10 mg 1 Capsule",
        "composition": "10 mg 1 Etretinate",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of severe psoriasis in adults",
            "contraindications": {
                "disease": "Symptoms of overdose include headache and vertigo",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The active metabolite responsible for etretinate s effects acitretin is a retinoid Retinoids have a structure similar to vitamin A and are involved in the normal growth of skin cells Acitretin works by inhibiting the excessive cell growth and keratinisation process by which skin cells become thickened due to the deposition of a protein within them seen in psoriasis It therefore reduces the thickening of the skin plaque formation and scaling",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00255",
                        "description": "The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The therapeutic efficacy of Estradiol can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The therapeutic efficacy of Mestranol can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The therapeutic efficacy of Desogestrel can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The therapeutic efficacy of Norethisterone can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The therapeutic efficacy of Norgestimate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Drospirenone can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The therapeutic efficacy of Gestodene can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The therapeutic efficacy of Dienogest can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "The therapeutic efficacy of Norgestrel can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "The therapeutic efficacy of Gestrinone can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "The therapeutic efficacy of Chlormadinone can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "The therapeutic efficacy of Quingestanol can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "The therapeutic efficacy of Demegestone can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00162",
                        "description": "The risk or severity of adverse effects can be increased when Vitamin A is combined with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of liver damage can be increased when Methotrexate is combined with Etretinate"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "Valproic acid may increase the Pseudotumor Cerebri activities of Etretinate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Clomocycline"
                    },
                    {
                        "drugbank-id": "DB00560",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Tigecycline"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Oxytetracycline"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Demeclocycline"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Metacycline"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Minocycline"
                    },
                    {
                        "drugbank-id": "DB01301",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Rolitetracycline"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12329",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Eravacycline"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Omadacycline"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Etretinate is combined with Penimepicycline"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "The risk or severity of pseudotumor cerebri can be increased when Etretinate is combined with Lymecycline"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}